Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16116 | 672 | 26.6 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
9 | 4 | COMPUTER SCIENCE, THEORY & METHODS//COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE//COMPUTER SCIENCE, INFORMATION SYSTEMS | 1247339 |
34 | 3 | STATISTICS & PROBABILITY//STAT//COMMUNICATIONS IN STATISTICS-THEORY AND METHODS | 105938 |
1075 | 2 | ADAPTIVE DESIGN//STATISTICS IN MEDICINE//STATISTICS & PROBABILITY | 9928 |
16116 | 1 | SUBGROUP ANALYSIS//MULTIREGIONAL CLINICAL TRIAL//MULTIREGIONAL TRIAL | 672 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SUBGROUP ANALYSIS | authKW | 847799 | 9% | 30% | 62 |
2 | MULTIREGIONAL CLINICAL TRIAL | authKW | 757297 | 3% | 83% | 20 |
3 | MULTIREGIONAL TRIAL | authKW | 408944 | 1% | 100% | 9 |
4 | QUALITATIVE INTERACTION | authKW | 344365 | 2% | 63% | 12 |
5 | BRIDGING STUDY | authKW | 290785 | 2% | 40% | 16 |
6 | CONSISTENT TREND | authKW | 272629 | 1% | 100% | 6 |
7 | SUBGROUP IDENTIFICATION | authKW | 230023 | 1% | 56% | 9 |
8 | REGIONAL SAMPLE SIZE | authKW | 227191 | 1% | 100% | 5 |
9 | SUBJECT TREATMENT INTERACTION | authKW | 181753 | 1% | 100% | 4 |
10 | SUBGROUP ANALYSES | authKW | 177341 | 2% | 35% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Statistics & Probability | 19135 | 41% | 0% | 276 |
2 | Mathematical & Computational Biology | 10805 | 23% | 0% | 157 |
3 | Medical Informatics | 8364 | 14% | 0% | 93 |
4 | Medicine, Research & Experimental | 2149 | 22% | 0% | 146 |
5 | Pharmacology & Pharmacy | 1203 | 26% | 0% | 176 |
6 | Health Care Sciences & Services | 1192 | 9% | 0% | 63 |
7 | Public, Environmental & Occupational Health | 823 | 15% | 0% | 103 |
8 | Oncology | 283 | 13% | 0% | 84 |
9 | Medicine, General & Internal | 111 | 8% | 0% | 51 |
10 | Biology | 93 | 4% | 0% | 27 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG DEV REGULATORY SCI PHARM | 90876 | 0% | 100% | 2 |
2 | OB OTS CDER DB1 | 90876 | 0% | 100% | 2 |
3 | OFF SCI POLICY GOVT AFFAIRS | 90876 | 0% | 100% | 2 |
4 | SUNNYBROOK WOMENS UNIT | 90876 | 0% | 100% | 2 |
5 | CLIN TRIAL STAT | 87375 | 1% | 38% | 5 |
6 | BIOSTAT DECIS SCI | 75097 | 1% | 18% | 9 |
7 | INNOVAT BIOMED INFORMAT | 58411 | 1% | 21% | 6 |
8 | OFF BIOSTAT | 53919 | 5% | 3% | 34 |
9 | BIOMETR BRANCH | 52637 | 4% | 4% | 26 |
10 | BIOMETR 1 | 47659 | 1% | 13% | 8 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 129209 | 8% | 6% | 51 |
2 | STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 53745 | 3% | 6% | 19 |
3 | CLINICAL TRIALS | 47956 | 4% | 4% | 28 |
4 | PHARMACEUTICAL STATISTICS | 45740 | 3% | 4% | 23 |
5 | STATISTICS IN MEDICINE | 36618 | 11% | 1% | 76 |
6 | DRUG INFORMATION JOURNAL | 34778 | 4% | 3% | 29 |
7 | CONTROLLED CLINICAL TRIALS | 9154 | 2% | 1% | 14 |
8 | CONTEMPORARY CLINICAL TRIALS | 6329 | 2% | 1% | 14 |
9 | BIOMETRICS | 6267 | 4% | 1% | 25 |
10 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 6120 | 1% | 2% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SUBGROUP ANALYSIS | 847799 | 9% | 30% | 62 | Search SUBGROUP+ANALYSIS | Search SUBGROUP+ANALYSIS |
2 | MULTIREGIONAL CLINICAL TRIAL | 757297 | 3% | 83% | 20 | Search MULTIREGIONAL+CLINICAL+TRIAL | Search MULTIREGIONAL+CLINICAL+TRIAL |
3 | MULTIREGIONAL TRIAL | 408944 | 1% | 100% | 9 | Search MULTIREGIONAL+TRIAL | Search MULTIREGIONAL+TRIAL |
4 | QUALITATIVE INTERACTION | 344365 | 2% | 63% | 12 | Search QUALITATIVE+INTERACTION | Search QUALITATIVE+INTERACTION |
5 | BRIDGING STUDY | 290785 | 2% | 40% | 16 | Search BRIDGING+STUDY | Search BRIDGING+STUDY |
6 | CONSISTENT TREND | 272629 | 1% | 100% | 6 | Search CONSISTENT+TREND | Search CONSISTENT+TREND |
7 | SUBGROUP IDENTIFICATION | 230023 | 1% | 56% | 9 | Search SUBGROUP+IDENTIFICATION | Search SUBGROUP+IDENTIFICATION |
8 | REGIONAL SAMPLE SIZE | 227191 | 1% | 100% | 5 | Search REGIONAL+SAMPLE+SIZE | Search REGIONAL+SAMPLE+SIZE |
9 | SUBJECT TREATMENT INTERACTION | 181753 | 1% | 100% | 4 | Search SUBJECT+TREATMENT+INTERACTION | Search SUBJECT+TREATMENT+INTERACTION |
10 | SUBGROUP ANALYSES | 177341 | 2% | 35% | 11 | Search SUBGROUP+ANALYSES | Search SUBGROUP+ANALYSES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TANNIOU, J , VAN DER TWEEL, I , TEERENSTRA, S , ROES, KCB , (2016) SUBGROUP ANALYSES IN CONFIRMATORY CLINICAL TRIALS: TIME TO BE SPECIFIC ABOUT THEIR PURPOSES.BMC MEDICAL RESEARCH METHODOLOGY. VOL. 16. ISSUE . P. - | 62 | 93% | 0 |
2 | LIPKOVICH, I , DMITRIENKO, A , D'AGOSTINO, RB , (2017) TUTORIAL IN BIOSTATISTICS: DATA-DRIVEN SUBGROUP IDENTIFICATION AND ANALYSIS IN CLINICAL TRIALS.STATISTICS IN MEDICINE. VOL. 36. ISSUE 1. P. 136 -196 | 39 | 50% | 1 |
3 | TAJIK, P , ZWINDERMAN, AH , MOL, BW , BOSSUYT, PM , (2013) TRIAL DESIGNS FOR PERSONALIZING CANCER CARE: A SYSTEMATIC REVIEW AND CLASSIFICATION.CLINICAL CANCER RESEARCH. VOL. 19. ISSUE 17. P. 4578 -4588 | 48 | 64% | 16 |
4 | ANTONIOU, M , JORGENSEN, AL , KOLAMUNNAGE-DONA, R , (2016) BIOMARKER-GUIDED ADAPTIVE TRIAL DESIGNS IN PHASE II AND PHASE III: A METHODOLOGICAL REVIEW.PLOS ONE. VOL. 11. ISSUE 2. P. - | 52 | 45% | 2 |
5 | AN, MW , SARGENT, DJ , MANDREKAR, SJ , RENFRO, LA , MALLICK, H , (2016) CLINICAL TRIAL DESIGNS INCORPORATING PREDICTIVE BIOMARKERS.CANCER TREATMENT REVIEWS. VOL. 43. ISSUE . P. 74 -82 | 41 | 64% | 0 |
6 | ONDRA, T , DMITRIENKO, A , FRIEDE, T , GRAF, A , MILLER, F , STALLARD, N , POSCH, M , (2016) METHODS FOR IDENTIFICATION AND CONFIRMATION OF TARGETED SUBGROUPS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW.JOURNAL OF BIOPHARMACEUTICAL STATISTICS. VOL. 26. ISSUE 1. P. 99 -119 | 37 | 51% | 2 |
7 | DMITRIENKO, A , MUYSERS, C , FRITSCH, A , LIPKOVICH, I , (2016) GENERAL GUIDANCE ON EXPLORATORY AND CONFIRMATORY SUBGROUP ANALYSIS IN LATE-STAGE CLINICAL TRIALS.JOURNAL OF BIOPHARMACEUTICAL STATISTICS. VOL. 26. ISSUE 1. P. 71 -98 | 26 | 67% | 0 |
8 | JANES, H , BROWN, MD , PEPE, MS , (2015) DESIGNING A STUDY TO EVALUATE THE BENEFIT OF A BIOMARKER FOR SELECTING PATIENT TREATMENT.STATISTICS IN MEDICINE. VOL. 34. ISSUE 27. P. 3503 -3515 | 22 | 73% | 0 |
9 | JANES, H , PEPE, MS , MCSHANE, LM , SARGENT, DJ , HEAGERTY, PJ , (2015) THE FUNDAMENTAL DIFFICULTY WITH EVALUATING THE ACCURACY OF BIOMARKERS FOR GUIDING TREATMENT.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 107. ISSUE 8. P. - | 18 | 82% | 3 |
10 | WILHELM-BENARTZI, CS , MT-ISA, S , FIORENTINO, F , BROWN, R , ASHBY, D , (2017) CHALLENGES AND METHODOLOGY IN THE INCORPORATION OF BIOMARKERS IN CANCER CLINICAL TRIALS.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 110. ISSUE . P. 49 -61 | 25 | 57% | 0 |
Classes with closest relation at Level 1 |